ClinicalTrials.gov
ClinicalTrials.gov Menu

Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01850732
Recruitment Status : Completed
First Posted : May 9, 2013
Last Update Posted : June 26, 2014
Sponsor:
Information provided by (Responsible Party):
Ville Vänni, North Karelia Central Hospital

Brief Summary:

The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with transient ischemic attack (TIA) symptoms. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these TIA patients, thus making screening of these patients (for AAA) more cost-efficient.

Study will be carried out as a prospective screening study. Data will be collected in North Karelia Central Hospital within one year. All male patients with TIA symptoms will be recruited for the study and screened for AAA with ultrasound.


Condition or disease Intervention/treatment Phase
Abdominal Aortic Aneurysm Other: Ultrasound of aorta Not Applicable

Study Type : Interventional  (Clinical Trial)
Primary Purpose: Screening
Official Title: Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms
Study Start Date : May 2013
Actual Primary Completion Date : June 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
ultrasound of aorta Other: Ultrasound of aorta



Primary Outcome Measures :
  1. Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound [ Time Frame: upon screening (collection of data will take one year) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • male patient who has had symptoms of transient ischemic attack (TIA)

Exclusion Criteria:

  • Patient's denial to participate
  • Female gender
  • Already diagnosed or treated abdominal aortic aneurysm

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01850732


Locations
Finland
North Carelia Central Hospital
Joensuu, Pohjois-Karjala, Finland, 80200
Sponsors and Collaborators
North Karelia Central Hospital

Responsible Party: Ville Vänni, General surgeon, North Karelia Central Hospital
ClinicalTrials.gov Identifier: NCT01850732     History of Changes
Other Study ID Numbers: AAA-03
First Posted: May 9, 2013    Key Record Dates
Last Update Posted: June 26, 2014
Last Verified: June 2014

Additional relevant MeSH terms:
Aneurysm
Aortic Aneurysm
Aortic Aneurysm, Abdominal
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases